Breakthrough Study: Ozempic and GLP-1 Medications Shown to Reduce Risk of 42 Health Conditions
2025-01-20Fortune
A groundbreaking study reveals that medications like Ozempic, which belong to the GLP-1 receptor agonist class, may significantly lower the risk of numerous health conditions, including heart attacks, Alzheimer's disease, and type 2 diabetes. The res ...Read more
